Bringing the fundamentals into focus…
Back to Neumora Therapeutics, Inc.
How Neumora Therapeutics, Inc. stacks up
NMRA · against 1,336 other Healthcare companies
Valuation
75/ 100
Above the middle of the pack.
Ranked #329 of 1,337 · scores higher than 75% of peers
Bars: peers in each 10-point band of the valuation score134 peers with a valuation score of 70–79, including NMRA · Click a bar to see the companies
Why valuation scores 75?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- lower earnings for the price paid: weaker than 99% of peers. Earnings yield: 243.4% vs peer median 1.5%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -288.4% vs peer median 4.0%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -168.3% vs peer median 0.0%
Metric by metric
Position: dot = NMRA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | NMRA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | -189.1% | 1.5% | 1% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | -471.8% | 4.2% | 1% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | -168.3% | -1.0% | 1% | 20% | |
| Book yieldHigher is better · 1,306 reported | 41.7% | 37.9% | 55% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around NMRA| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 329 | 2.3B USD | 75 | 74 | |
| 329 | 38.9B USD | 75 | 56 | |
| 329 | 655M AUD (≈$432M) | 75 | 62 | |
| 329 | 1.8B USD | 75 | 80 | |
| 329 | 107M USD | 75 | 31 | |
| 329 | 2.7B USD | 75 | 84 | |
| 329 | 540M ILS (≈$146M) | 75 | 49 | |
| 329 | 464M USD | 75 | 53 | |
| 329 | 646M USD | 75 | 46 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score